Concepedia

Alan Moore

AM

16

Publications

1.2K

Citations

13

H-Index

1986

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Medtronic (United States)

Novartis (Sweden)

Universidade Estadual de Campinas (UNICAMP)

Alan Moore is an author at Novartis (Switzerland) specializing in medicine, neurology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1986–2022

16

Publications

16

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

Marilisa M. Guerreiro, Ulf Vigonius, H. Pöhlmann et al. · Epilepsy Research · 1997 · 241 citations

, , +4

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy

W. Christe, Günter Krämer, Ulf Vigonius et al. · Epilepsy Research · 1997 · 217 citations

, , +3

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

Pierre Alfred Bill, Ulf Vigonius, H. Pöhlmann et al. · Epilepsy Research · 1997 · 215 citations

, , +4

Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database

Gorana Capkun, Frank Dahlke, Raquel Lahoz et al. · Multiple Sclerosis and Related Disorders · 2015 · 106 citations · Full text

NO EVIDENCE FOR INFECTION OF HUMAN CELLS WITH PORCINE ENDOGENOUS RETROVIRUS (PERV) AFTER EXPOSURE TO PORCINE FETAL NEURONAL CELLS1

Jonathan Dinsmore, Carolyn J. Manhart, R. Raineri et al. · Transplantation · 2000 · 105 citations

Rows per page

1–5 of 16